Evotec SE

EVO | NASDAQ | 4 Obserwujący

$4.05

1.00%

$0.04

Obserwuj

Overview Metrics Financials

Company Quality

Profitability Score

7/100

Solvency Score

55/100

Dividends

Dividends data currently unavailable.

Earnings

Earnings data currently unavailable.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Drug Manufacturers - Specialty & Generic

Branża

Dr. Christian Wojczewski Ph.D.

Prezes

4766

Pracownicy

Hamburg

Siedziba główna

Kraj

Evotec SE (EVT) is a German pharmaceutical company focused on drug research and development. The company provides services to pharmaceutical and biotechnology firms in the areas of drug discovery, testing, and drug development. Evotec collaborates with various research institutions and pharmaceutical companies worldwide to identify and develop new drugs for different diseases. The company specializes in areas such as oncology, neurology, metabolic disorders, and infectious diseases. Evotec has a long history of research and innovation in the pharmaceutical industry, and its technologies and expertise are highly regarded in the world of medical research. Evotec SE (EVT) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company with a significant role in discovering new drugs and therapeutic approaches.

Key Metrics TTM

Valuation

Market cap.

$1.3B

Enterprise Value

$977M

Price to Earnings

-12.19

Price to Sales

1.60

Price to Book

2.77

Price to Cash Flow

-15.71

Profitability

Return on Assets

-10.64%

Return on Equity

-21.53%

Return on Invested Capital

-9.55%

Gross Margin

13.62%

Operating Margin

-18.31%

Net Margin

-26.26%

Liquidity

Quick Ratio

1.93

Current Ratio

2.03

Cash Ratio

0.80

Inventory Turnover

20.32

Asset Turnover

0.41

Total Liabilities

$1B

Solvency

Debt to Assets

0.00

Debt to Equity

N/A

Interest Coverage

-12.62

Equity Ratio

0.47

Long-term Debt to Cap.

0.00

Altman Z-Score

0.64

Performance

Performance data currently unavailable.

Earnings Waterfall

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.